Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,910
-10 (-0.07%)
Oct 11, 2024, 9:00 AM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 324.66 billion as of October 11, 2024. Its market cap has decreased by -50.40% in one year.

Market Cap
324.66B
Enterprise Value
277.82B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,910.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 324.66B, an increase of 102.61%. That is a compound annual growth rate of 18.98%.

History

DateMarket Cap% Change
Oct 14, 2024324.66B-37.10%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 20202,517.20B1,470.89%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition